Advocates of the Make America Healthy Again agenda have expressed skepticism over President Donald Trump’s agreement with ...

Even after Trump’s new deal, obesity drugs are still too expensive.

The president’s agreement with drug companies involves a range of prices, depending on dose, product and how you’re paying.

President Trump's plan drops the price of Ozempic and Wegovy for Americans, with plans for Medicare to cover the popular ...

A new US government deal with drugmakers Eli Lilly and Novo Nordisk will slash prices for popular weight-loss drugs like ...

Medicare will cover semaglutide (Wegovy) and tirzepatide (Zepbound) for their weight management indications for people with ...

Danish company vies with Pfizer for control of US biotech as they seek edge in growing market for weight-loss drugs ...

A small study helps explain why some people taking Wegovy and similar weight-loss drugs cut back on alcohol, offering insight ...

Certain blockbuster obesity drugs will be available for as little as $149 per month and more Medicare enrollees will have ...

Popular GLP-1 drugs like Ozempic will get cheaper in exchange for partial Medicare coverage, opening up new markets for Eli ...

Press Release President Donald J. Trump announced agreements with Eli Lilly and Novo Nordisk to reduce prices of available ...